CurAegis Technologies, Inc. (CRGS)
$0.0001
0.00 (0.00%)
Rating:
Recommendation:
-
| Symbol | CRGS |
|---|---|
| Price | $0.0001 |
| Beta | 15.611 |
| Volume Avg. | 0.00M |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 0.0001-0.0001 |
| 1y Target Est | - |
| DCF Unlevered | CRGS DCF -> | |
|---|---|---|
| DCF Levered | CRGS LDCF -> | |
| ROE | 16.54% | Buy |
| ROA | -772.18% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -102.00% | Sell |
| P/E | -0 | Neutral |
| P/B | -0 | Neutral |
About
Download (Excel)Mr. James R. Donnelly
Technology
Scientific & Technical Instruments
Other OTC
CurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.